5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | NEUTRAL | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.87▼ | 7.87▼ | 7.87▼ | 7.86▲ | 7.88▼ |
MA10 | 7.87▼ | 7.87▼ | 7.87▲ | 7.88▼ | 5.05▲ |
MA20 | 7.87▼ | 7.87▲ | 7.86▲ | 7.06▲ | 3.64▲ |
MA50 | 7.87▲ | 7.87▲ | 7.87▼ | 4.03▲ | 3.30▲ |
MA100 | 7.87▲ | 7.87▼ | 7.88▼ | 3.17▲ | 3.82▲ |
MA200 | 7.87▲ | 7.88▼ | 5.71▲ | 3.05▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▼ | 0.000▲ | 0.001▲ | -0.134▼ | 0.722▲ |
RSI | 48.169▼ | 52.643▲ | 53.277▲ | 88.467▲ | 80.536▲ |
STOCH | 41.667 | 46.667 | 81.111▲ | 24.735 | 94.042▲ |
WILL %R | -100.000▼ | -33.333 | -33.333 | -70.000 | -1.205▲ |
CCI | -37.037 | 66.361 | 76.923 | -46.161 | 102.904▲ |
Friday, June 13, 2025 09:41 AM
Vigil Neuroscience, Inc. (NASDAQ: VIGL)’s sale to Sanofi. Under the terms of the proposed transaction, Vigil shareholders will receive $8.00 per share in cash and a non-tradeable contingent ...
|
Monday, June 09, 2025 06:54 AM
Vigil Neuroscience, Inc. (VIGL) closed the last trading session at $7.88, gaining 225.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets ...
|
Thursday, June 05, 2025 02:31 PM
Sanofi's $470M Vigil Neuroscience, Inc. acquisition highlights VG-3927's potential in Alzheimer's. Click here to find out why I maintain a Hold rating on VIGL.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 7.87 | 7.88 | 7.87 | 7.87 | 526,174 |
13/06/25 | 7.87 | 7.875 | 7.85 | 7.86 | 3,564,822 |
12/06/25 | 7.87 | 7.88 | 7.84 | 7.87 | 3,583,135 |
11/06/25 | 7.88 | 7.88 | 7.86 | 7.86 | 2,437,624 |
10/06/25 | 7.88 | 7.88 | 7.855 | 7.86 | 1,956,236 |
09/06/25 | 7.89 | 7.90 | 7.85 | 7.88 | 2,363,824 |
06/06/25 | 7.89 | 7.89 | 7.87 | 7.88 | 3,524,697 |
05/06/25 | 7.89 | 7.91 | 7.88 | 7.88 | 1,238,158 |
04/06/25 | 7.90 | 7.90 | 7.88 | 7.90 | 864,652 |
03/06/25 | 7.93 | 7.94 | 7.90 | 7.91 | 434,797 |
|
|
||||
|
|
||||
|
|